Glaukos outlines $600M–$620M 2026 revenue outlook as Epioxa launch and iDose TR drive growth

3 hours ago 1

Earnings Call Insights: Glaukos Corporation (GKOS) Q3 2025

Management View

  • CEO Thomas Burns began by highlighting "record third quarter consolidated net sales of $133.5 million, up 38% on a reported basis or 37% on a constant currency basis versus the year ago quarter." He announced an

Seeking Alpha's Disclaimer: The earnings call insights are compilations of earnings call transcripts and other content available on the Seeking Alpha website. The insights are generated by an AI tool and have not been curated or reviewed by editors. Due to inherent limitations in using AI-based tools, the accuracy, completeness, or timeliness of the earnings call insights cannot be guaranteed.

Please see full earnings call transcripts

here.

The earnings call insights are intended for informational purposes only. Seeking Alpha does not take account of your objectives or your financial situation and does not offer any personalized investment advice. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank.

Read Entire Article